Enter assignee name

EPO Patents = 2

Trademarks = 3

Forward Citations = 5

Loading Chart...

14 inventors (with patents filed for the assignee):

Johannes Jelle Van Der Vliet (5 out of 7 patents)

Tanja Denise De Gruijl (4 out of 8 patents)

Renée Cornelia Gerarda De Bruin (3 out of 5 patents)

4. Hendrik Marinus Willem Verheul (3 out of 5 patents)

5. Roeland Lameris (3 out of 4 patents)

6. Paul Willem Henri Ida Parren (2 out of 2 patents)

7. Robertus Cornelis Roovers (1 out of 5 patents)

8. Peter Alexander Gerardus Maria Machielsen (1 out of 1 patent)

9. Victoria Iglesias Guimarais (1 out of 1 patent)

10. Lisa Anna King (1 out of 1 patent)

11. Iris De Weerdt (1 out of 1 patent)

12. Arnon Philip Kater (1 out of 1 patent)

13. David Lutje Hulsik (1 out of 1 patent)

14. Roland Lameris (0 patent)

5 patents: Sort by Forward Citations

1. 12428493 - Antibodies that bind PSMA and gamma-delta T cell receptors (2025-09-30),

2. 12110328 - Single domain antibodies targeting CD1d (2024-10-08),

3. 12077586 - Bispecific antibodies for use in the treatment of hematological malignancies (2024-09-03),

4. 11591394 - Single domain antibodies targeting CD1d (2023-02-28),

5. 11384145 - Immunoglobulins binding human Vγ9Vδ2 T cell receptors (2022-07-12),

Lava Therapeutics N.V. is a clinical-stage biotechnology company focused on developing a new class of T cell engagers for the treatment of cancer. The company's proprietary technology platform is designed to harness the power of the immune system to target and eliminate cancer cells. Lava's lead product candidates are based on its unique approach to T cell engagement, aiming to improve the efficacy and safety of cancer therapies. The company is committed to advancing innovative treatments that can significantly impact patient outcomes in oncology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

5 Patents

#24 in Utrecht

#1,105 in Netherlands

Utrecht, Netherlands

Lava Therapeutics N.v.